Central Bank of India
NSE: CENTRALBKPublic Sector Bank
Share price
₹29.99
-1.48% close of 8 Oct 2026
Price-based ratios (P/B, dividend yield, EV/EBITDA) are as of 7 Oct 2026, the close above is 8 Oct 2026.
Business score
How strong the business is, in one number. The parts behind it are in Pro.
64
out of 100 · worked out 8 Oct 2026
Your ratios
The numbers you want to see first. Tap Edit to change them.
Market cap
₹27,144 Cr
P/E ratio
5.9
P/B ratio
0.7
ROCE
5.6%
ROE
11.9%
Dividend yield
3.9%
Price & valuation chart
How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.
Answers
Simple answers to the questions investors ask most, from the company's own numbers.
How fast it has been growing
Sales grew 9.4% over the past year, and 6.1% a year over its longer record. Meanwhile what it keeps on lending improved from -3.5% to 2.3% over the last two years.
Whether it grew faster than its sector
It grew 6.1% a year against a sector median of 16.0% — 9.8 percentage points slower.
Room to re-rate, or risk of de-rating
At 5.9× earnings against a market that pays 23.9× across 2199 companies we can price. Its own industry sits at 6.3×, across 5 companies. It is against its own five-year median of 15.2×, the 0th percentile of its own range.
Whether growth justifies the valuation
Priced at 0.2 times its growth rate, on earnings growth of 39%.
| Profit growth | Price per ₹1 profit | Per 1% growth | |
|---|---|---|---|
| Central Bank of India — this one | 39%/yr | 5.9× | ₹0.15 |
| State Bank of India | 14%/yr | 10.3× | ₹0.74 |
| Punjab National Bank | 76%/yr | 6.0× | ₹0.08 |
| Union Bank of India | 32%/yr | 6.3× | ₹0.20 |
| Bank of Baroda | 10%/yr | 5.5× | ₹0.55 |
| Indian Bank | 28%/yr | 8.5× | ₹0.30 |
Compared with companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
How it compares with its peers
Against companies the exchange files under the same label (Public Sector Bank), it ranks 10 of 12 on returns, 11 of 12 on growth. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
What makes it hard to beat — and is that still true?
No durable advantage shows in the numbers: it earns 11.9% on capital, ahead of 17% of companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.
Whether its growth pays for itself
This question does not fit a lender: the money it lends out is its day-to-day outflow and the deposits or premiums it takes are the inflow, so a cash bridge cannot say whether its growth pays for itself. Look at the return on owners' money instead.
Profit reality check
Is the profit real cash? Simple checks on the accounts. Facts only, not advice.
Not enough filed accounts to run these checks yet.
Latest result
What the last results showed. Whether management kept its word is in Pro.
Results are expected soon.
Checklist before you investPRO
Points for and against, in one list.
Key numbers & peers
The main numbers grouped by topic, and how the company compares with similar ones.
Price
- Market cap
- ₹27,144 Cr
- Prev close
- ₹29.99
- 52w High
- ₹40.9
- 52w Low
- ₹29.3
- Enterprise value
- ₹8,201 Cr
- Beta
- 1.2
- Price CAGR 1y
- -19.0%
- Price CAGR 3y
- -15.0%
- Price CAGR 5y
- 6.0%
- Price CAGR 10y
- -11.0%
Ratios
- Return on assets
- 0.8%
- PEG ratio
- 0.2
- P/E ratio
- 5.9
- P/B ratio
- 0.7
- EV / EBITDA
- 40.9
- Industry P/E
- 7.4
- ROCE
- 5.6%
- ROCE 5y average
- —
- ROE
- 11.9%
- Debt / Equity
- 0.8
- Interest coverage
- —
- Dividend yield
- 3.9%
- ROE 3y average
- 11.0%
- ROE last year
- 12.0%
Annual P&L
- Annual revenue
- ₹36,168 Cr
- Annual profit
- ₹4,531 Cr
- Operating margin
- 2.0%
- Net profit margin
- 12.5%
- EBITDA margin
- 1.8%
- Sales growth 3y
- 12.1%
- Sales growth 5y
- 9.6%
- Profit growth 3y
- 39.0%
- Profit growth 5y
- 46.0%
- EPS
- ₹5.0
- Sales growth TTM
- 9.0%
- Profit growth TTM
- 8.0%
- Dividend payout
- 36.0%
Quarter P&L
- Sales latest quarter
- ₹9,726 Cr
- Profit latest quarter
- ₹1,325 Cr
- YoY quarterly sales growth
- 12.8%
- YoY quarterly profit growth
- 3.2%
- OPM latest quarter
- 8.0%
Balance Sheet
- Book Value
- ₹43.1
- Face Value
- ₹10.0
- Total debt
- ₹31,854 Cr
- Total cash
- ₹18,953 Cr
- Borrowings
- ₹31,854 Cr
- Reserves / Equity
- 3.3
Cash Flow
- Operating cash flow
- ₹2,804 Cr
- Free cash flow
- ₹2,350 Cr
- FCF yield
- —
- Net cash flow
- ₹1,637 Cr
Shareholding
- Promoter holding
- 81.2%
- FII holding
- 0.9%
- DII holding
- 10.9%
- Public holding
- 6.9%
Peer comparison
| Company | Price ₹ | P/E | Mkt cap ₹ Cr | Div yield % | Profit qtr ₹ Cr | Profit var % | Sales qtr ₹ Cr | Sales var % | ROCE % |
|---|---|---|---|---|---|---|---|---|---|
| SBI | 954.00 | 10.5 | 8,81,995 | 1.82 | 25,120.9 | 13.7 | 1,36,240.5 | 8.4 | 6.1 |
| Union Bank (I) | 173.15 | 6.4 | 1,32,207 | 2.89 | 5,641.5 | 27.4 | 27,427.1 | 1.2 | 6.3 |
| Punjab Natl.Bank | 114.59 | 6.0 | 1,31,604 | 2.62 | 5,834.8 | 174.3 | 33,589.2 | 3.1 | 6.1 |
| Bank of Baroda | 234.55 | 5.5 | 1,21,258 | 3.62 | 1,839.3 | 64.6 | 35,114.5 | 6.8 | 5.6 |
| Indian Bank | 828.30 | 8.8 | 1,12,065 | 2.20 | 3,357.4 | 20.5 | 18,095.1 | 11.1 | 6.3 |
| Canara Bank | 119.15 | 5.5 | 1,08,233 | 3.52 | 5,182.1 | 3.5 | 32,957.2 | 4.5 | 6.5 |
| Bank of Maha | 84.15 | 8.6 | 64,885 | 2.61 | 2,023.3 | 34.5 | 8,034.7 | 13.9 | 6.0 |
| Central Bank | 30.44 | 6.0 | 27,525 | 3.94 | 1,324.6 | 8.0 | 9,725.9 | 12.8 | 5.6 |
| Median | 116.87 | 7.5 | 86,559 | 2.62 | 2,663.7 | 25.3 | 19,096.0 | 8.8 | 6.0 |
Competes with: Bank of Baroda, Bank of India, Bank of Maharashtra, Canara Bank, Indian Bank, Indian Overseas Bank, Punjab National Bank, State Bank of India, Union Bank of India
Quarterly results
Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.
| Line item | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7,259 | 7,377 | 7,842 | 8,371 | 8,367 | 8,235 | 8,542 | 8,653 | 8,623 | 8,777 | 9,070 | 9,698 | 9,726 |
| Expenses | 3,118 | 3,534 | 3,377 | 3,561 | 3,920 | 3,500 | 3,373 | 3,968 | 3,381 | 3,328 | 3,853 | 3,573 | 3,129 |
| Financing Profit | 79 | -495 | -207 | -1 | -354 | -71 | 185 | -553 | 21 | -28 | -335 | 448 | 803 |
| Financing Margin % | 1 | -7 | -3 | -0 | -4 | -1 | 2 | -6 | 0 | -0 | -4 | 5 | 8 |
| Other Income | 959 | 1,062 | 1,329 | 1,363 | 1,166 | 1,649 | 1,232 | 1,723 | 1,857 | 1,507 | 1,927 | 1,161 | 988 |
| Interest | 4,062 | 4,338 | 4,672 | 4,811 | 4,801 | 4,807 | 4,984 | 5,238 | 5,222 | 5,476 | 5,552 | 5,677 | 5,794 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 1,038 | 567 | 1,122 | 1,363 | 812 | 1,578 | 1,418 | 1,171 | 1,878 | 1,479 | 1,592 | 1,609 | 1,791 |
| Tax % | 59 | -7 | 35 | 40 | -9 | 42 | 32 | 11 | 33 | 18 | 21 | 54 | 26 |
| Net Profit | 498 | 623 | 738 | 817 | 945 | 926 | 966 | 1,106 | 1,284 | 1,234 | 1,265 | 748 | 1,325 |
| EPS in Rs | 0.57 | 0.72 | 0.85 | 0.94 | 1.09 | 1.06 | 1.11 | 1.22 | 1.42 | 1.36 | 1.40 | 0.82 | 1.46 |
| Gross NPA % | 4.95 | 4.61 | 4.50 | 4.50 | 4.54 | 4.59 | 3.87 | 3.18 | 3.14 | 3.02 | 2.71 | 2.67 | 2.61 |
| Net NPA % | 1.75 | 1.64 | 1.28 | 1.24 | 0.75 | 0.70 | 0.61 | 0.56 | 0.50 | 0.49 | 0.46 | 0.50 | 0.51 |
| Gross NPA | 8,638 | 8,827 | 8,726 | 9,185 | 9,225 | ||||||||
| Income on Investments | 2,340 | 2,588 | 2,682 | 2,600 | 2,645 | ||||||||
| Interest on Advances | 5,932 | 5,668 | 6,091 | 6,359 | 6,756 | ||||||||
| Interest on RBI and Inter-bank Balances | 275 | 454 | 256 | 269 | 253 | ||||||||
| Net NPA | 1,308 | 1,364 | 1,414 | 1,666 | 1,715 |
Filed only on the standalone basis, so shown from it: Gross NPA, Income on Investments, Interest on Advances, Interest on RBI and Inter-bank Balances, Net NPA.
Profit & loss
Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.
| Line item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 26,476 | 25,988 | 24,775 | 24,163 | 22,749 | 23,676 | 22,830 | 22,903 | 25,657 | 30,849 | 33,797 | 36,168 | 37,270 |
| Expenses | 8,620 | 11,529 | 12,744 | 14,015 | 14,580 | 12,135 | 12,419 | 10,477 | 12,778 | 13,099 | 14,102 | 13,578 | 13,884 |
| Financing Profit | -1,344 | -4,430 | -6,136 | -7,455 | -7,766 | -4,464 | -4,133 | -934 | -1,026 | -133 | -134 | 664 | 888 |
| Financing Margin % | -5 | -17 | -25 | -31 | -34 | -19 | -18 | -4 | -4 | -0 | -0 | 2 | 2 |
| Other Income | 1,900 | 2,019 | 2,871 | 2,620 | 2,416 | 3,622 | 2,994 | 2,986 | 4,164 | 4,814 | 5,784 | 6,463 | 5,584 |
| Interest | 19,200 | 18,889 | 18,166 | 17,603 | 15,935 | 16,005 | 14,543 | 13,361 | 13,905 | 17,882 | 19,830 | 21,926 | 22,498 |
| Depreciation | 230 | 240 | 258 | 260 | 278 | 285 | 293 | 297 | 386 | 500 | 558 | 530 | 0 |
| Profit before tax | 327 | -2,651 | -3,523 | -5,096 | -5,628 | -1,127 | -1,431 | 1,755 | 2,752 | 4,181 | 5,092 | 6,597 | 6,472 |
| Tax % | -89 | -47 | -31 | 0 | 0 | 0 | -30 | 38 | 39 | 36 | 23 | 31 | |
| Net Profit | 670 | -1,392 | -2,457 | -5,134 | -5,611 | -1,252 | -995 | 1,083 | 1,688 | 2,677 | 3,943 | 4,531 | 4,571 |
| EPS in Rs | 4.02 | -8.26 | -13 | -20 | -14 | -2.20 | -1.70 | 1.24 | 1.93 | 3.07 | 4.35 | 5 | 5.04 |
| Dividend Payout % | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 36 |
Compounded growth
Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.
Compounded sales growth
- 10 years
- 3%
- 5 years
- 10%
- 3 years
- 12%
- TTM
- 9%
Compounded profit growth
- 10 years
- 18%
- 5 years
- 46%
- 3 years
- 39%
- TTM
- 8%
Stock price CAGR
- 10 years
- -11%
- 5 years
- 6%
- 3 years
- -15%
- 1 year
- -19%
Return on equity
- 10 years
- -1%
- 5 years
- 9%
- 3 years
- 11%
- Last year
- 12%
Balance sheet
What the company owns and what it owes, at the end of each year. ₹ crore.
| Line item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1,658 | 1,690 | 1,902 | 2,618 | 4,047 | 5,710 | 5,876 | 8,681 | 8,681 | 8,681 | 9,051 | 9,051 |
| Reserves | 16,077 | 16,818 | 16,309 | 15,592 | 15,349 | 15,827 | 20,621 | 18,868 | 20,536 | 23,693 | 27,830 | 29,950 |
| Borrowing | 19,777 | 9,503 | 9,623 | 6,026 | 5,640 | 6,076 | 5,760 | 7,663 | 8,334 | 20,013 | 21,820 | 31,854 |
| Deposits | 2,62,263 | 2,66,686 | 2,97,309 | 2,95,354 | 3,00,311 | 3,14,201 | 3,30,328 | 3,43,165 | 3,59,775 | 3,85,541 | 4,13,271 | 4,68,444 |
| Other Liabilities | 12,991 | 11,924 | 9,551 | 7,759 | 6,538 | 15,337 | 7,390 | 8,915 | 9,754 | 9,844 | 8,485 | 11,780 |
| Total Liabilities | 3,12,766 | 3,06,621 | 3,34,695 | 3,27,349 | 3,31,885 | 3,57,151 | 3,69,974 | 3,87,292 | 4,07,080 | 4,47,772 | 4,80,457 | 5,51,079 |
| Fixed Assets | 2,843 | 4,369 | 4,300 | 4,353 | 4,320 | 4,346 | 5,142 | 4,964 | 4,786 | 5,345 | 5,214 | 5,202 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 89,921 | 89,087 | 92,277 | 1,02,769 | 1,25,453 | 1,42,526 | 1,48,518 | 1,40,775 | 1,36,569 | 1,44,010 | 1,41,652 | 1,57,607 |
| Advances | 3,38,209 | |||||||||||
| Other Assets | 2,20,001 | 2,13,165 | 2,38,118 | 2,20,227 | 2,02,112 | 2,10,279 | 2,16,315 | 2,41,553 | 2,65,725 | 2,98,416 | 3,33,591 | 3,88,270 |
| Total Assets | 3,12,766 | 3,06,621 | 3,34,695 | 3,27,349 | 3,31,885 | 3,57,151 | 3,69,974 | 3,87,292 | 4,07,080 | 4,47,772 | 4,80,457 | 5,51,079 |
Cash flows
Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.
| Line item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 2,274 | 281 | 61,871 | -44,376 | -14,510 | 1,726 | -2,003 | 14,277 | -8,786 | -5,910 | -2,460 | 2,804 |
| Cash from Investing Activity | -332 | -149 | -189 | -310 | -251 | -315 | -202 | -133 | -209 | -584 | -451 | -454 |
| Cash from Financing Activity | 510 | 599 | 1,543 | 5,154 | 6,796 | 3,396 | 5,055 | 0 | 0 | 0 | 1,500 | -713 |
| Net Cash Flow | 2,452 | 732 | 63,225 | -39,533 | -7,965 | 4,807 | 2,849 | 14,143 | -8,995 | -6,494 | -1,410 | 1,637 |
| Free Cash Flow | 1,989 | 132 | 61,682 | -44,687 | -14,761 | 1,411 | -2,206 | 14,143 | -8,995 | -6,494 | -2,910 | 2,350 |
Ratios
How fast customers pay, how long stock sits, and how well capital earns — year by year.
| Line item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE % | 4 | -8 | -13 | -28 | -30 | -6 | -4 | 4 | 6 | 9 | 11 | 12 |
Price trend
The price as a Renko brick chart: small moves drop out so the bigger path stands out.
Every brick is the same size, about one typical day's move. A new brick needs a full brick's move; turning the other way needs two. Bricks show where the price went, not where it will go.
Open interestPRO
Where option traders are positioned on this stock.
Industry numbers
The numbers that matter most in this industry, from the company's own filings.
1 when an audit qualification is filed as repetitive
0.00flag
2026-03-31
capital adequacy (CRAR) %
18.28pct
2026-06-30
CASA ratio %
46.61pct
2026-06-30
cost-to-income %
55.40pct
2026-06-30
the company's own unlisted debt securities in default at period end
0.00cr
2026-06-30
gross NPA %
2.60pct
2026-06-30
the company's own loans / revolving facilities in default at period end (standalone filing)
0.00cr
2026-06-30
loan growth %
28.58pct
2026-06-30
total loans / revolving facilities outstanding at period end, the base of loan_default_cr
0.00cr
2026-06-30
net NPA %
0.49pct
2026-06-30
net interest margin %
3.06pct
2026-06-30
guarantees / comfort given for promoter, promoter group, directors and KMP
0.00cr
2026-03-31
loans outstanding to promoter, promoter group, directors and KMP (governance filing)
0.00cr
2026-03-31
security given for the borrowing of promoter, promoter group, directors and KMP
0.00cr
2026-03-31
provision coverage %
95.86pct
2026-06-30
FY revenue / permanent employees + workers, same basis (calc)
1,05,96,723inr
2026-03-31
return on assets %
0.89pct
2026-03-31
News
News and filings about Central Bank of India. Open one to see why it matters.
No recent news for this company.
Supply chain
Who it buys from, sells to and competes with — as recorded in our map of company links.
Competes with
Depends on the price of
- Bond Markets
- Interest Rates
Sells products of
- Bajaj Allianz General Insurance
- Generali Central Insurance Co Ltd
- Generali Central Life Insurance Co Ltd
- Life Insurance Corporation
- Tata AIA Life Insurance
- The New India Assurance Company Limited
Products sold by
Buys from
- AAA Technologies Limited · IT / information-security audit services
- Alankit Limited · Business Correspondent / last-mile banking services; one of the 9 partner banks named in t…
- BLS E-Services Limited · business correspondent / customer service point banking services
- Dynacons Systems & Solutions Limited · Branch IT infrastructure augmentation
- Emkay Global Financial Services Limited · investment banking; book running lead manager for INR 1500 crore QIP
About
What the company is, from our own records: where it sits, where it makes things, and what it is made of.
- Sector
- Financial Services
- Industry
- Public Sector Bank
- Classification
- Financial Services › Public Sector Bank
- ISIN
- INE483A01010
Business segments
- Retail Banking Operations · 44%
- Treasury Operations · 32%
- Wholesale Banking Operations · 23%
- Other Banking Operations · 0%
News impact
Big market events that reach Central Bank of India, and how the effect spreads.
30 Sept, 20:12 IST · Market event · medium impact
Kerala HC judgment gives Centre another route to tackle high-priced patented medicines
Court lets government get patented drugs made cheaply for public health, hurting costly patent sellers but helping generic and ingredient makers.
Who it hits first
- A court says the central government can ask another company to make costly patented medicines for public health schemes, if legal steps are met.
- Makers of high-priced patented drugs, like AstraZeneca India and Sun Pharma's specialty arm, face cheaper government-backed copies.
- Generic drug and ingredient makers, like Cipla, Divi's Labs and Laurus Labs, could win new government supply orders.
- Hospitals and pharmacies see little instant change; the fight is over who makes the pills.
Who may gain
- Cipla (generic drug maker) — could be picked to make low-cost versions for government programmes.
- Divi's Laboratories (drug-ingredient maker) — more generic volumes mean more ingredient orders.
- Laurus Labs (contract drug maker) — similar ingredient and manufacturing upside.
- Patients in public-health schemes — cheaper access if the route is used.
Along the supply chain
Downstream
Downstream are government hospitals, clinics and distributors in public-health schemes, which get cheaper patented drugs, while patent sellers lose sales.
Upstream
Upstream are ingredient and raw-material suppliers like Divi's Labs and Laurus Labs, which gain if generic copies need more active ingredients.
Where demand moves
Business
Government health programmes may shift orders from costly patent sellers to approved generic makers; overall pill volumes stay similar, but who gets paid changes.
Capital
Investors turn cautious on patent-heavy sellers and look toward generic and ingredient makers that could win state orders.
How it spreads across sectors
Healthcare
Patent-holding sellers face price cuts while approved generic and ingredient makers gain order chances; hospitals see little direct change.
When it plays out
Immediate
In 1–7 days drug stocks wobble as investors reprice patent risk and generic hopes.
Medium term
In 1–6 months any first government authorisation to a generic maker sets prices and volumes.
Short term
In 1–4 weeks lawyers parse the judgment and government hints which drugs or schemes come first.
20 Jun, 04:23 IST · Market event · high impact
Centre to raise Rs 13,000 crore via OFS in three state-run banks
Who it hits first
- Likely OFS candidates: IOB (govt 92.44%), UCO (90.95%), CENTRALBK (81.19%), PSB (93.85%) — immediate -2 to -5% on OFS day
- PSU bank index pressure broadly
Who may gain
- SBIN, BANKBARODA (already below 75% govt stake) — capital rotation tailwind
- Private banks (HDFCBANK, ICICIBANK) — sector rotation from PSU OFS pressure
Along the supply chain
Downstream
Govt fiscal receipt of Rs 13,000 cr supports FY27 disinvestment target; modest positive for fiscal-deficit narrative
Upstream
OFS does not have a direct supply-chain link — purely capital-flow event affecting equity float of named PSU banks
Where demand moves
Business
OFS supply creates immediate selling pressure on named PSU banks; absorbed largely by domestic mutual funds and LIC
Capital
Capital rotates from OFS-affected PSU banks into stronger PSUs (SBIN, BANKBARODA) and private banks; modest pressure on overall bank-nifty for 1-2 days around OFS announcement
How it spreads across sectors
Financial Services
PSU bank cluster faces supply pressure; private banks/large PSU banks rotation beneficiaries
Government Disinvestment / Capital Markets
Boost to FY27 disinvestment receipts
When it plays out
Immediate
Sentiment negative for likely-OFS candidates (IOB, UCO, CENTRALBK, PSB); SBIN/BANKBARODA modest rotation tailwind
Medium term
Compliance achieved; sector overhang clears; rerating possible on absorbed-supply names
Short term
OFS launch dates over 4-8 weeks; each OFS window sees -3 to -5% intra-window then recovers 1-2% post-event
Dividends, splits & big trades
Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.
Dividends
| 8 May 2026 | interim | ₹0.6 |
|---|---|---|
| 23 Jan 2026 | interim | ₹0.2 |
| 27 Oct 2025 | interim | ₹0.2 |
| 25 Jul 2025 | interim | ₹0.2 |
| 4 Jul 2025 | unspecified | ₹0.1875 |
| 23 Jun 2015 | unspecified | ₹0.5 |
| 20 Jun 2013 | unspecified | ₹2.5 |
| 21 Jun 2012 | unspecified | ₹2 |
Splits, bonuses & buybacks
- daily-prices repair: 9 rows from NSE's archive (replace 1, delete 1, insert 7), 2016-10-30..2026-02-01 (docs/flat_day_repair.md)1× · 30 Oct 2016
Documents
Annual reports, results presentations and earnings calls, straight from the source.
- Earnings call · Q1FY2717 Jul 2026
- Annual report · 2025-269 Jul 2026
- Results presentation30 Jun 2026
Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.